Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
E2814 + Lecanemab for Alzheimer's Disease
Recruiting0 awardsPhase 2
San Francisco, California
This trial aims to find out how different doses of E2814, when given at the same time as lecanemab, affect the levels of a specific protein in the cerebrospinal fluid
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service